Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Jun;13(6):899–904. doi: 10.1128/aac.13.6.899

Comparison of Netilmicin with Gentamicin in the Therapy of Experimental Escherichia coli Meningitis

W Michael Scheld 1, Robert S Brown Jr 1, Merle A Sande 1
PMCID: PMC352359  PMID: 354518

Abstract

Netilmicin (SCH 20569), a new broad-spectrum aminoglycoside derived from sisomicin, was compared with gentamicin in the therapy of experimental Escherichia coli meningitis in rabbits. Meningitis was produced in 48 animals by the intracisternal inoculation of 105E. coli colony-forming units. The minimum bactericidal concentration was 2 μg/ml against the test strain for both gentamicin and netilmicin. The two aminoglycosides demonstrated comparable penetration into the cerebrospinal fluid (CSF). The mean percent penetration [(CSF concentration/serum concentration) × 100%] was 22.5 ± 6.0 and 20.6 ± 7.2 for netilmicin and gentamicin, respectively (P = 0.18). However, netilmicin achieved bactericidal activity in the CSF at lower levels than did gentamicin. When mean CSF concentrations ranged from 4 to 8 μg/ml, mean CSF bacterial titers decreased 2.98 logs in rabbits treated with netilmicin but only 0.16 log in rabbits treated with gentamicin. A 2-log decrease in CSF bacterial counts was produced by a mean CSF concentration of 1.4 μg of netilmicin per ml as compared to 14.1 μg of gentamicin per ml. Because of its reduced toxicity and greater in vivo bactericidal activity, netilmicin may offer an advantage over gentamicin in the therapy of gram-negative bacillary meningitis.

Full text

PDF
904

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alcid D. V., Seligman S. J. Simplified assay for gentamicin in the presence of other antibiotics. Antimicrob Agents Chemother. 1973 May;3(5):559–561. doi: 10.1128/aac.3.5.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Briedis D. J., Robson H. G. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae. Antimicrob Agents Chemother. 1976 Oct;10(4):592–597. doi: 10.1128/aac.10.4.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown K. N., Benedictson J., Swanby S. In vitro comparison of gentamicin, tobramycin, sisomicin, and netilmicin. Antimicrob Agents Chemother. 1976 Oct;10(4):768–769. doi: 10.1128/aac.10.4.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chang M. J., Escobedo M., Anderson D. C., Hillman L., Feigin R. D. Kanamycin and gentamicin treatment of neonatal sepsis and meningitis. Pediatrics. 1975 Nov;56(5):695–699. [PubMed] [Google Scholar]
  5. Dacey R. G., Sande M. A. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother. 1974 Oct;6(4):437–441. doi: 10.1128/aac.6.4.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dhawan V., Marso E., Martin W. J., Young L. S. In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrob Agents Chemother. 1977 Jan;11(1):64–73. doi: 10.1128/aac.11.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Flournoy D. J. Sisomicin versus netilmicin: in vitro susceptibility testing. Antimicrob Agents Chemother. 1976 Nov;10(5):864–865. doi: 10.1128/aac.10.5.864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fu K. P., Neu H. C. In vitro study of netilmicin compared with other aminoglycosides. Antimicrob Agents Chemother. 1976 Sep;10(3):526–534. doi: 10.1128/aac.10.3.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fu K. P., Neu H. C. In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother. 1976 Sep;10(3):511–518. doi: 10.1128/aac.10.3.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Graybill J. R., Mann J., Charache P. Intrathecal gentamicin in treatment of bacterial meningitis. Johns Hopkins Med J. 1973 Jul;133(1):51–56. [PubMed] [Google Scholar]
  11. Kabins S. A., Nathan C., Cohen S. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics. Antimicrob Agents Chemother. 1976 Jul;10(1):139–145. doi: 10.1128/aac.10.1.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kaiser A. B., McGee Z. A. Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med. 1975 Dec 11;293(24):1215–1220. doi: 10.1056/NEJM197512112932401. [DOI] [PubMed] [Google Scholar]
  13. Kantor R. J., Norden C. W. In vitro activity of netilmicin, gentamicin, and amikacin. Antimicrob Agents Chemother. 1977 Jan;11(1):126–131. doi: 10.1128/aac.11.1.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lorber J., Kalhan S. C., Mahgrefte B. Treatment of ventriculitis with gentamicin and cloxacillin in infants born with spina bifida. Arch Dis Child. 1970 Apr;45(240):178–185. doi: 10.1136/adc.45.240.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Luft F. C., Yum M. N., Kleit S. A. Comparative nephrotoxicities of netilmicin and gentamicin in rats. Antimicrob Agents Chemother. 1976 Nov;10(5):845–849. doi: 10.1128/aac.10.5.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MacLowry J. D., Jaqua M. J., Selepak S. T. Detailed methodology and implementation of a semiautomated serial dilution microtechnique for antimicrobial susceptibility testing. Appl Microbiol. 1970 Jul;20(1):46–53. doi: 10.1128/am.20.1.46-53.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mangi R. J., Quintiliani R., Andriole V. T. Gram-negative bacillary meningitis. Am J Med. 1975 Dec;59(6):829–836. doi: 10.1016/0002-9343(75)90468-4. [DOI] [PubMed] [Google Scholar]
  18. McCracken G. H., Jr The rate of bacteriologic response to antimicrobial therapy in neonatal meningitis. Am J Dis Child. 1972 Jun;123(6):547–553. doi: 10.1001/archpedi.1972.02110120071004. [DOI] [PubMed] [Google Scholar]
  19. Meyer R. D., Draus L. L., Pasieczinik K. A. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics. Antimicrob Agents Chemother. 1976 Oct;10(4):677–681. doi: 10.1128/aac.10.4.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Meyers B. R., Hirschman S. Z. Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin. Antimicrob Agents Chemother. 1977 Jan;11(1):118–121. doi: 10.1128/aac.11.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Miller G. H., Arcieri G., Weinstein M. J., Waitz J. A. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. Antimicrob Agents Chemother. 1976 Nov;10(5):827–836. doi: 10.1128/aac.10.5.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Moellering R. C., Jr, Fischer E. G. Relationship of intraventricular gentamicin levels to cure of meningitis. Report of a case of Proteus meningitis successfully treated with intraventricular gentamicin. J Pediatr. 1972 Sep;81(3):534–537. doi: 10.1016/s0022-3476(72)80182-3. [DOI] [PubMed] [Google Scholar]
  23. Pogwizd S. M., Lerner S. A. In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens. Antimicrob Agents Chemother. 1976 Dec;10(6):878–884. doi: 10.1128/aac.10.6.878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rahal J. J., Jr, Hyams P. J., Simberkoff M. S., Rubinstein E. Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients. N Engl J Med. 1974 Jun 20;290(25):1394–1398. doi: 10.1056/NEJM197406202902502. [DOI] [PubMed] [Google Scholar]
  25. Rahal J. J., Jr, Simberkoff M. S., Kagan K., Moldover N. H. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms. Antimicrob Agents Chemother. 1976 Apr;9(4):595–599. doi: 10.1128/aac.9.4.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rahal J. J., Jr Treatment of gram-negative bacillary meningitis in adults. Ann Intern Med. 1972 Aug;77(2):295–302. doi: 10.7326/0003-4819-77-2-295. [DOI] [PubMed] [Google Scholar]
  27. Smith J. A., Morgan J. R., Mogyoros M. In vitro activity of netilmicin. Antimicrob Agents Chemother. 1977 Feb;11(2):362–364. doi: 10.1128/aac.11.2.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Strausbaugh L. J., Mandaleris C. D., Sande M. A. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis. J Lab Clin Med. 1977 Apr;89(4):692–701. [PubMed] [Google Scholar]
  29. Strausbaugh L. J., Sande M. A. Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits. J Infect Dis. 1978 Mar;137(3):251–260. doi: 10.1093/infdis/137.3.251. [DOI] [PubMed] [Google Scholar]
  30. Watanakunakorn C. Comparative in vitro activity of Sch 20656, netilmicin, gentamicin, and tobramycin. Antimicrob Agents Chemother. 1976 Aug;10(2):382–383. doi: 10.1128/aac.10.2.382. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES